ICMR To Strengthen IPR Unit To Safeguard And Commercialize Scientific Innovations

Mumbai: In a strategic move to bolster its Intellectual Property Rights (IPR) capabilities, the Indian Council of Medical Research (ICMR) has issued an invitation for expressions of interest from its in-house scientists and technical officers. This call aims to attract qualified personnel for transfer or posting to the IPR Unit at ICMR headquarters, New Delhi. The initiative underscores ICMR’s vision to safeguard and commercialize scientific innovations developed under its aegis.

A senior official at ICMR, emphasized the importance of this initiative stating, “Our goal is to strengthen the IPR Unit to ensure that the scientific innovations generated through ICMR-funded research are adequately protected and effectively commercialized. This will not only benefit the scientific community but also enhance public health outcomes.”

The ICMR has outlined a clear mandate for its IPR Unit, which includes educating scientists on the critical need to protect new knowledge through intellectual property rights. This includes ownership of biological and other materials and data generated using ICMR funds, creating robust procedures at ICMR institutions to capture, assess, and protect new intellectual property.

It also includes maintaining national and international databases to provide ICMR scientists with up-to-date patent information relevant to their fields, offering comprehensive technological, professional, and legal services to assist in filing patents both domestically and internationally.

This will encourage and aid universities and other institutions in protecting and commercializing knowledge generated with ICMR support and developing policies that ensure maximal public health benefit and fair returns on investments from ICMR research. This will help create an advisory body to the Indian government on IP issues concerning public health and help form strategic partnerships with national and international S&T agencies and industries to market new inventions and develop professional knowledge networks.

The ICMR is seeking two scientists (non-medical) and two technical officers from the following disciplines: microbiology, biochemistry, biotechnology, biomedical sciences, life sciences, molecular biology, pharmacology, biology, biosciences, medical genetics, immunology, zoology, and bioinformatics.

Interested candidates must submit their applications through the proper channel by July 25, 2024. Applications should be sent to the email address admn2355@gmail.com.

The ICMR’s proactive approach to reinforcing its IPR Unit highlights the critical role of intellectual property management in advancing medical research. By attracting skilled professionals, ICMR aims to enhance its capacity to protect and leverage scientific discoveries, ultimately contributing to improved healthcare solutions and innovations.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks